ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

161 hedge funds and large institutions have $770M invested in Achillion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$125M
Puts
$39.3M
Net Calls
Net Calls Change

Top Buyers

1 +$36M
2 +$27.5M
3 +$12.4M
4
Goldman Sachs
Goldman Sachs
New York
+$9.47M
5
Millennium Management
Millennium Management
New York
+$9.33M

Top Sellers

1 -$158M
2 -$48.8M
3 -$25.4M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$7.78M
5
Morgan Stanley
Morgan Stanley
New York
-$7.72M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$451K
102
$412K
103
$411K
104
$395K
105
$343K
106
$311K
107
$304K
108
$274K
109
$265K
110
$259K
111
$250K
112
$250K
113
$250K
114
$250K
115
$233K
116
$222K
117
$214K
118
$208K
119
$204K
120
$203K
121
$201K
122
$200K
123
$200K
124
$200K
125
$195K